Doxazosin Mesylate Tablet
Product Images NDC 71610-965

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 71610-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0965 53)

Label (71610 0965 53)
This is a medication labeled as Doxazosin with 60 tablets in the bottle. The National Drug Code (NDC) is 71610-965-53. It appears to be from batch 1 with GTIN number 10371610065537. No expiration date is mentioned.*
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Doxazosin Structural Formula (Image 01)

Doxazosin Structural Formula (Image 01)
FDA Label Image

Table 3. (Image 02)

Table 3. (Image 02)
This text provides a summary of effectiveness data from placebo-controlled trials evaluating the maximum flow rate (mL/sec) and symptom score changes with the drug CARDURA. The trials include different studies with varying dosages and durations. The data outlines the improvement in symptom scores and maximum flow rates for patients with hypertension and benign prostatic hyperplasia (BPH) receiving CARDURA compared to a placebo. The text also mentions specific assessment tools used in these studies, such as the AUA questionnaire and Modified Boyarsky Questionnaire. Additionally, the post-dose efficacy phase and the number of patients receiving different dosages of CARDURA are noted.*
FDA Label Image

Figure 1 – Study 1 (Image 03)

Figure 1 – Study 1 (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.